Skip NavigationSkip to Content

Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells

  1. Author:
    Honjo, Y.
    Hrycyna, C. A.
    Yan, Q. W.
    Medina-Perez, W. Y.
    Robey, R. W.
    van de Laar, A.
    Litman, T.
    Dean, M.
    Bates, S. E.
  2. Author Address

    NCI, Canc Therapeut Branch, Ctr Canc Res, NIH, Bldg 10, Room 12M226, 9000 Rockville Pike, Bethesda, MD 20892 USA. NCI, Canc Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA. Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA. Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark. NCI, Lab Genom Divers, Frederick, MD 21702 USA. Bates SE NCI, Canc Therapeut Branch, Ctr Canc Res, NIH, Bldg 10, Room 12M226, 9000 Rockville Pike, Bethesda, MD 20892 USA.
    1. Year: 2001
  1. Journal: Cancer Research
    1. 61
    2. 18
    3. Pages: 6635-6639
  2. Type of Article: Article
  1. Abstract:

    A disparity was noted in the transport of rhodamine 123 among nine MXR/BCRP/ABCP-overexpressing cells studied; all demonstrated mitoxantrone transport, whereas only two effluxed rhodamine 123. When the MXR/BCRP/ABCP gene was sequenced in the cell lines studied, differences were noted at amino acid 482, predicted to be at the start of the third transmembrane domain. Sequencing genomic DNA revealed wild-type MXR/BCRP/ABCP to have an arginine at position 482. Cells having a threonine or glycine at position 482 were able to efflux rhodamine 123, whereas cells having an arginine were not. A vaccinia virus expression system confirmed that rhodamine as well as doxorubicin efflux is observed with R482T or R482G but not with the wild-type R482; all three MXR/BCRP/ABCP forms transported mitoxantrone. Cross-resistance studies suggest that, compared with wild-type MXR/BCRP/ABCP, cells having an R482T mutation have higher anthracycline resistance, whereas an R482G mutation seems to confer relatively less resistance to SN-38 and topotecan. These results suggest that amino acid 482 has a crucial role in MXR/BCRP/ABCP function and that mutation of a single amino acid residue significantly changes substrate specificity, thus altering the drug resistance phenotype.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel